Dr. Roger S. McIntyre: Ketamine in Mood Disorders CRTCE

Event Title: Diabetes, Mood Disorders and ADHD; Brain Hazards and Implications for Improving Clinical outcomes
Event Date: May 12 2018
Event Location: Mississauga, Ontario
Speaker:
Roger McIntyre, MD, FRCPC.
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
University of Toronto
Topic:
Ketamine and Glutamatergic Treatment as Rapid Onset Treatments in Depression; Scientific Rationale and Clinical Application
Check out the Canadian Rapid Treatment Center of Excellence
www.crtce.com/
Talk 4 of 4